Difference between revisions of "Cribriform pattern within invasive prostate carcinoma"

From Libre Pathology
Jump to navigation Jump to search
m (vauthors)
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
'''Cribriform pattern within invasive prostate carcinoma''' has been shown to be poor prognosticator in [[prostate cancer]].<ref>{{Cite journal  | last1 = Iczkowski | first1 = KA. | last2 = Paner | first2 = GP. | last3 = Van der Kwast | first3 = T. | title = The New Realization About Cribriform Prostate Cancer. | journal = Adv Anat Pathol | volume = 25 | issue = 1 | pages = 31-37 | month = Jan | year = 2018 | doi = 10.1097/PAP.0000000000000168 | PMID = 28820750 }}</ref>
'''Cribriform pattern within invasive prostate carcinoma''' has been shown to be poor prognosticator in [[prostate cancer]].<ref>{{Cite journal  | last1 = Iczkowski | first1 = KA. | last2 = Paner | first2 = GP. | last3 = Van der Kwast | first3 = T. | title = The New Realization About Cribriform Prostate Cancer. | journal = Adv Anat Pathol | volume = 25 | issue = 1 | pages = 31-37 | month = Jan | year = 2018 | doi = 10.1097/PAP.0000000000000168 | PMID = 28820750 }}</ref>
==General==
In the morphologic context, ''invasive cribriform carcinoma'' may be lumped with ''intraductal carcinoma of the prostate'', as immunostains are required to differentiate.<ref name=pmid28530220>{{cite journal |vauthors=Kweldam CF, Kümmerlin IP, Nieboer D, Steyerberg EW, Bangma CH, Incrocci L, van der Kwast TH, Roobol MJ, van Leenders GJ |title=Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4&amp;#61;7 prostate cancer |journal=Mod. Pathol. |volume=30 |issue=8 |pages=1126–1132 |date=August 2017 |pmid=28530220 |doi=10.1038/modpathol.2017.29 |url=}}</ref>


==Microscopic==
==Microscopic==
Line 8: Line 5:
*[[Cribriform architecture]].
*[[Cribriform architecture]].
*Loss of basal cells.
*Loss of basal cells.
Note:
*In the morphologic context, ''invasive cribriform carcinoma'' may be lumped with ''intraductal carcinoma of the prostate'', as immunostains are required to differentiate.<ref name=pmid28530220>{{cite journal |authors=Kweldam CF, Kümmerlin IP, Nieboer D, Steyerberg EW, Bangma CH, Incrocci L, van der Kwast TH, Roobol MJ, van Leenders GJ |title=Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4&amp;#61;7 prostate cancer |journal=Mod. Pathol. |volume=30 |issue=8 |pages=1126–1132 |date=August 2017 |pmid=28530220 |doi=10.1038/modpathol.2017.29 |url=}}</ref>


==See also==
==See also==

Latest revision as of 17:14, 25 March 2021

Cribriform pattern within invasive prostate carcinoma has been shown to be poor prognosticator in prostate cancer.[1]

Microscopic

Features:[citation needed]

Note:

  • In the morphologic context, invasive cribriform carcinoma may be lumped with intraductal carcinoma of the prostate, as immunostains are required to differentiate.[2]

See also

References

  1. ↑ Iczkowski, KA.; Paner, GP.; Van der Kwast, T. (Jan 2018). "The New Realization About Cribriform Prostate Cancer.". Adv Anat Pathol 25 (1): 31-37. doi:10.1097/PAP.0000000000000168. PMID 28820750.
  2. ↑ Kweldam CF, Kümmerlin IP, Nieboer D, Steyerberg EW, Bangma CH, Incrocci L, van der Kwast TH, Roobol MJ, van Leenders GJ (August 2017). "Presence of invasive cribriform or intraductal growth at biopsy outperforms percentage grade 4 in predicting outcome of Gleason score 3+4&#61;7 prostate cancer". Mod. Pathol. 30 (8): 1126–1132. doi:10.1038/modpathol.2017.29. PMID 28530220.
Retrieved from "https://librepathology.org/w/index.php?title=Cribriform_pattern_within_invasive_prostate_carcinoma&oldid=51212"